Leaflet DIENILLE film-coated tablets


Indicated for: contraception

Substance: dienogest + ethinylestradiol (progestogen + estrogen)

ATC: G03FA15 (Genito urinary system and sex hormones | Progestogens and estrogens in combination | Progestogens and estrogens, fixed combinations)

The combination of dienogest and ethinylestradiol is used as an oral contraceptive to prevent pregnancy. Dienogest is a progestin, and ethinylestradiol is an estrogen, both working to inhibit ovulation and alter the uterine lining.

The medication is taken orally, usually once daily at the same time, following a 21- or 28-day cycle. It is important to adhere to the administration schedule to ensure contraceptive effectiveness.

Side effects may include nausea, headaches, breast tenderness, or mood changes. In rare cases, severe reactions such as venous thromboembolism may occur.

This combination is not recommended for pregnant women, breastfeeding mothers, or patients with a history of thrombosis, severe liver disease, or hypersensitivity to any of the components.

General data about DIENILLE

  • Substance: dienogest + ethinylestradiol
  • Date of last drug list: 01-10-2015
  • Commercial code: W56004001
  • Pharmaceutical form: film-coated tablets
  • Quantity: 21
  • Product type: generic
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).